CA2864366C - Construction de lipide comportant un lipide amphipathique, du cholesterol, du dicetyl phosphate et un recepteur hepatocyte liant une molecule - Google Patents
Construction de lipide comportant un lipide amphipathique, du cholesterol, du dicetyl phosphate et un recepteur hepatocyte liant une molecule Download PDFInfo
- Publication number
- CA2864366C CA2864366C CA2864366A CA2864366A CA2864366C CA 2864366 C CA2864366 C CA 2864366C CA 2864366 A CA2864366 A CA 2864366A CA 2864366 A CA2864366 A CA 2864366A CA 2864366 C CA2864366 C CA 2864366C
- Authority
- CA
- Canada
- Prior art keywords
- biotin
- insulin
- construct
- glycero
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Linvention instantanée est tirée dune construction de lipide comportant un lipide amphipathique, du cholestérol, du dicétyl phosphate et une molécule liant un récepteur hépatocyte. La composition peut également comprendre un mélange dinsuline libre et dinsuline associée à la construction. La composition peut être modifiée pour protéger linsuline et le complexe de la dégradation. Linvention comprend également des procédés de fabrication de la composition, des méthodes de chargement de linsuline dans la composition et des méthodes de traitement des personnes atteintes de diabète.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68387805P | 2005-05-23 | 2005-05-23 | |
| US60/683,878 | 2005-05-23 | ||
| US11/384,659 US7858116B2 (en) | 1998-05-19 | 2006-03-20 | Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal |
| US11/384,728 | 2006-03-20 | ||
| US11/384,728 US7871641B2 (en) | 1998-05-19 | 2006-03-20 | Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammal |
| US11/384,659 | 2006-03-20 | ||
| CA2609402A CA2609402C (fr) | 2005-05-23 | 2006-05-16 | Construction lipidique pour l'administration d'insuline a un mammifere |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2609402A Division CA2609402C (fr) | 2005-05-23 | 2006-05-16 | Construction lipidique pour l'administration d'insuline a un mammifere |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2864366A1 CA2864366A1 (fr) | 2006-11-30 |
| CA2864366C true CA2864366C (fr) | 2016-04-05 |
Family
ID=51787285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2864366A Active CA2864366C (fr) | 2005-05-23 | 2006-05-16 | Construction de lipide comportant un lipide amphipathique, du cholesterol, du dicetyl phosphate et un recepteur hepatocyte liant une molecule |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2864366C (fr) |
-
2006
- 2006-05-16 CA CA2864366A patent/CA2864366C/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2864366A1 (fr) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2859015T3 (en) | LIGANDS MODIFIED BY CIRCULAR MODIFICATION AS AGONISTS AND ANTAGONISTS | |
| US10463616B2 (en) | Lipid construct for delivery of insulin to a mammal | |
| US20250288521A1 (en) | Orally bioavailable lipid-based constructs | |
| US8257735B2 (en) | Method of increasing the bioavailability of recombinant human insulin isophane in a patient | |
| EP3391876B1 (fr) | Construction lipidique pour administration d'insuline à un mammifère | |
| US7871641B2 (en) | Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammal | |
| US20220110870A1 (en) | Lipid construct for delivery of insulin to a mammal | |
| KR101389226B1 (ko) | 포유동물에게 인슐린을 전달하기 위한 지질 구조물 | |
| AU2012247063B2 (en) | Lipid construct for delivery of insulin to a mammal | |
| CA2864366C (fr) | Construction de lipide comportant un lipide amphipathique, du cholesterol, du dicetyl phosphate et un recepteur hepatocyte liant une molecule | |
| US20070218117A1 (en) | Supra molecular construct for delivery of interferon to a mammal | |
| AU2006249479A1 (en) | Lipid construct for delivery of interferon to a mammal | |
| DK1883394T3 (en) | Lipid construct for delivering insulin to a mammal | |
| HK1262603B (en) | Lipid construct for delivery of insulin to a mammal | |
| HK1262603A1 (en) | Lipid construct for delivery of insulin to a mammal | |
| HK1116396B (en) | Lipid construct for delivery of insulin to a mammal | |
| HK1116396A (en) | Lipid construct for delivery of insulin to a mammal | |
| AU2015249189A1 (en) | Lipid construct for delivery of insulin to a mammal | |
| WO2011022396A1 (fr) | Construction lipidique pour ladministration dinsuline à un mammifère | |
| HK1259503A1 (en) | Orally bioavailable lipid-based constructs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140918 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 19TH ANNIV.) - STANDARD Year of fee payment: 19 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250409 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250409 |